Prosecution Insights
Last updated: April 19, 2026

Examiner: CHAO, ALLEN

Tech Center 1600 • Art Units: 1622 1624

This examiner grants 0% of resolved cases

Performance Statistics

%
Allow Rate
-60.0% vs TC avg
18
Total Applications
Interview Lift
1175
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

0%
§101 Eligibility
25.0%
§102 Novelty
43.2%
§103 Obviousness
20.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18449807 TREATMENT OF BREAST CANCER USING COMBINATION THERAPIES COMPRISING GDC-9545 AND IPATASERTIB Non-Final OA Genentech, Inc.
18284531 CRYSTAL FORMS OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE Non-Final OA Bristol-Myers Squibb Company
18335687 DIHYDROOXADIAZINONE COMPOUND AND PHARMACEUTICAL USE THEREOF Non-Final OA Japan Tobacco Inc.
18219447 PROCESS FOR PREPARING PHOSPHONATE ESTERS Final Rejection ENTEGRIS, INC.
18339773 USES OF ORAI1-SPECIFIC CALCIUM CHANNELS IN TREATMENT OF ORAL CANCER Non-Final OA New York University
18562666 METHOD FOR CRYSTALLIZATION OF AROMATIC AMINO ACIDS, ENABLING SUSTAINABLE CYCLE OF AMMONIA Non-Final OA CJ CheilJedang Corporation
17757701 SYNTHETIC TRITERPENOIDS WITH NITROGEN-BASED SUBSTITUENTS AT C-17 AND METHODS OF USE THEREOF Non-Final OA REATA PHARMACEUTICALS, INC.
18512088 METHODS FOR TREATING POXVIRUS INFECTIONS Non-Final OA Gilead Sciences, Inc.
18511106 PHARMACEUTICAL COMPOSITION FOR PREVENTION, ALLEVIATION OR TREATMENT OF SARCOPENIA, CONTAINING ROR-alpha ACTIVATOR JC1-40 Non-Final OA SEOUL NATIONAL UNIVERSITY R & DB FOUNDATION
18014881 VACCINE ADJUVANTS AND METHODS OF SYNTHESIZING AND USING THE SAME Non-Final OA Amyris, Inc.
18508200 ORAL Pt (IV) ANTICANCER PRODRUG CONTAINING 3-BROMOPYRUVATE AS AXIAL LIGAND Non-Final OA Kunming Medical University
18284515 PROCESS FOR THE PREPARATION OF CYCLEN Non-Final OA SERICHIM SRL
18284523 HEAD LICE TREATMENT Non-Final OA Nitoff Limited
18228086 Processes for the Preparation of Fenfluramine Non-Final OA Apotex Inc.
18546342 PROCESS FOR PREPARING INDOCYANINE GREEN Non-Final OA ICROM Srl
18263434 ORAL PREPARATION CONTAINING JAK INHIBITOR OR SALT THEREOF OR CRYSTAL FORM THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Non-Final OA ZHUHAI UNITED LABORATORIES CO., LTD.
18223654 TRIGEMINAL CUE FOR WILDLIFE REPELLENTS Non-Final OA Arkion Life Sciences, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month